Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Capital-Expenditures" stands at 13.12 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Eisai Co. Ltd.'s second quarter result of 2.46 Billion JPY for the item "Capital Expenditures" represents a decrease of -45.66 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 2.46 Billion JPY for the item "Capital Expenditures" represents an increase of 11.09 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 13.12 Billion JPY for the item "Capital Expenditures" represents an increase of 1.91 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -29.55 percent compared to the value the year prior.
The 1 year change in percent is -29.55.
The 3 year change in percent is -66.57.
The 5 year change in percent is -63.47.
The 10 year change in percent is -68.66.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Capital Expenditures | 905,699,262,464.00 |
![]() | Johnson & Johnson - Capital Expenditures | 486,508,953,600.00 |
![]() | AbbVie Inc - Capital Expenditures | 399,570,305,024.00 |
![]() | Roche Holding AG - Capital Expenditures | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Capital Expenditures | 280,205,508,085.11 |